IMMUNITYBIO, INC. Other Comprehensive Income (Loss), Net of Tax
IMMUNITYBIO, INC. (IBRX) reported Other Comprehensive Income (Loss), Net of Tax of -$169.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$169.00K.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$1.50M, a 108.01% decline year-over-year.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $23.96M, a 2088.04% increase year-over-year.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was -$7.57M, a 6920.72% decline year-over-year.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $27.76M, a 2236.53% increase from fiscal 2024.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $1.19M.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$173.00K, a 196.65% decline from fiscal 2022.
- IMMUNITYBIO, INC. other comprehensive income (loss), net of tax for fiscal 2022 was $179.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$169.00K 10-Q · filed 2026-08-04 | -$1.67M 10-Q · filed 2026-08-04 | $22.29M derived: sum of 3 quarters · filed 2026-08-04 | $14.72M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$1.50M 10-Q · filed 2026-08-04 | $22.46M derived: sum of 2 quarters · filed 2026-08-04 | $14.88M derived: sum of 3 quarters · filed 2026-08-04 | $7.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $23.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $16.39M derived: sum of 2 quarters · filed 2026-02-23 | $9.00M derived: sum of 3 quarters · filed 2026-08-04 | $27.76M 10-K · filed 2026-02-23 | ||||
| 2025-09-30 | -$7.57M 10-Q · filed 2025-11-05 | -$14.96M derived: sum of 2 quarters · filed 2026-08-04 | $3.80M 10-Q · filed 2025-11-05 | $4.89M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$7.39M 10-Q · filed 2026-08-04 | $11.37M 10-Q · filed 2026-08-04 | $12.46M derived: sum of 3 quarters · filed 2026-08-04 | $12.58M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $18.76M 10-Q · filed 2026-08-04 | $19.85M derived: sum of 2 quarters · filed 2026-08-04 | $19.96M derived: sum of 3 quarters · filed 2026-08-04 | $19.96M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2024-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.21M derived: sum of 2 quarters · filed 2026-02-23 | $1.21M derived: sum of 3 quarters · filed 2026-02-23 | $1.19M 10-K · filed 2026-02-23 | ||||
| 2024-09-30 | $111.00K 10-Q · filed 2025-11-05 | $110.00K derived: sum of 2 quarters · filed 2025-11-05 | $93.00K 10-Q · filed 2025-11-05 | -$689.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-06-30 | -$1.00K 10-Q · filed 2025-11-05 | -$18.00K 10-Q · filed 2025-08-05 | -$800.00K derived: sum of 3 quarters · filed 2026-02-23 | $32.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2024-03-31 | -$17.00K 10-Q · filed 2025-11-05 | -$799.00K derived: sum of 2 quarters · filed 2026-02-23 | $33.00K derived: sum of 3 quarters · filed 2026-02-23 | $26.00K derived: sum of 4 quarters · filed 2026-02-23 | ||||
| 2023-12-31 | -$782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $50.00K derived: sum of 2 quarters · filed 2026-02-23 | $43.00K derived: sum of 3 quarters · filed 2026-02-23 | -$173.00K 10-K · filed 2026-02-23 | ||||
| 2023-09-30 | $832.00K 10-Q · filed 2024-11-12 | $825.00K derived: sum of 2 quarters · filed 2024-11-12 | $609.00K 10-Q · filed 2024-11-12 | $982.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | -$7.00K 10-Q · filed 2024-11-12 | -$223.00K 10-Q · filed 2024-08-12 | $150.00K derived: sum of 3 quarters · filed 2025-03-03 | $70.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | -$216.00K 10-Q · filed 2024-11-12 | $157.00K derived: sum of 2 quarters · filed 2025-03-03 | $77.00K derived: sum of 3 quarters · filed 2025-03-03 | $334.00K derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $293.00K derived: sum of 2 quarters · filed 2025-03-03 | $550.00K derived: sum of 3 quarters · filed 2025-03-03 | $179.00K 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | -$80.00K 10-Q · filed 2023-11-09 | $177.00K derived: sum of 2 quarters · filed 2023-11-09 | -$194.00K 10-Q · filed 2023-11-09 | -$243.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $257.00K 10-Q · filed 2023-11-09 | -$114.00K 10-Q · filed 2023-08-08 | -$163.00K derived: sum of 3 quarters · filed 2024-03-19 | -$147.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | -$371.00K 10-Q · filed 2023-11-09 | -$420.00K derived: sum of 2 quarters · filed 2024-03-19 | -$404.00K derived: sum of 3 quarters · filed 2024-03-19 | -$329.00K derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2021-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$33.00K derived: sum of 2 quarters · filed 2024-03-19 | $42.00K derived: sum of 3 quarters · filed 2024-03-19 | -$118.00K 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | $16.00K 10-Q · filed 2022-11-09 | $91.00K derived: sum of 2 quarters · filed 2022-11-09 | -$69.00K 10-Q · filed 2022-11-09 | $174.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $75.00K 10-Q · filed 2022-11-09 | -$85.00K 10-Q · filed 2022-08-08 | $158.00K derived: sum of 3 quarters · filed 2023-03-01 | $112.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | -$160.00K 10-Q · filed 2022-11-09 | $83.00K derived: sum of 2 quarters · filed 2023-03-01 | $37.00K derived: sum of 3 quarters · filed 2023-03-01 | $2.00K derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $197.00K derived: sum of 2 quarters · filed 2023-03-01 | $162.00K derived: sum of 3 quarters · filed 2023-03-01 | $209.00K 10-K · filed 2023-03-01 | -$17.00K 10-K · filed 2021-03-04 | |||
| 2020-09-30 | -$46.00K 10-Q · filed 2021-11-12 | -$17.00K 10-Q · filed 2020-11-09 | -$81.00K derived: sum of 2 quarters · filed 2021-11-12 | -$34.00K 10-Q · filed 2021-11-12 | -$12.00K 10-Q · filed 2020-11-09 | -$121.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$35.00K 10-Q · filed 2021-08-12 | $28.00K 10-Q · filed 2020-08-07 | $12.00K 10-Q · filed 2021-08-12 | $5.00K 10-Q · filed 2020-08-07 | -$75.00K derived: sum of 3 quarters · filed 2022-03-01 | -$44.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $47.00K 10-Q · filed 2021-05-14 | -$23.00K 10-Q · filed 2020-05-11 | -$40.00K derived: sum of 2 quarters · filed 2022-03-01 | -$9.00K derived: sum of 3 quarters · filed 2022-03-01 | $113.00K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$56.00K derived: sum of 2 quarters · filed 2022-03-01 | $66.00K derived: sum of 3 quarters · filed 2022-03-01 | $127.00K 10-K · filed 2022-03-01 | $162.00K 10-K · filed 2020-03-25 | |||
| 2019-09-30 | $31.00K 10-Q · filed 2020-11-09 | $153.00K derived: sum of 2 quarters · filed 2020-11-09 | $214.00K 10-Q · filed 2020-11-09 | $295.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-06-30 | $122.00K 10-Q · filed 2020-08-07 | $183.00K 10-Q · filed 2020-08-07 | $264.00K derived: sum of 3 quarters · filed 2021-03-04 | $364.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2019-03-31 | $61.00K 10-Q · filed 2020-05-11 | $142.00K derived: sum of 2 quarters · filed 2021-03-04 | $242.00K derived: sum of 3 quarters · filed 2021-03-04 | $349.00K derived: sum of 4 quarters · filed 2021-03-04 | ||||
| 2018-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $181.00K derived: sum of 2 quarters · filed 2021-03-04 | $288.00K derived: sum of 3 quarters · filed 2021-03-04 | $114.00K 10-K · filed 2021-03-04 | ||||
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-05 | $207.00K derived: sum of 2 quarters · filed 2019-11-05 | $33.00K 10-Q · filed 2019-11-05 | $138.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-06-30 | $107.00K 10-Q · filed 2019-08-06 | -$67.00K 10-Q · filed 2019-08-06 | $38.00K derived: sum of 3 quarters · filed 2020-03-25 | $73.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2018-03-31 | -$174.00K 10-Q · filed 2019-05-08 | -$69.00K derived: sum of 2 quarters · filed 2020-03-25 | -$34.00K derived: sum of 3 quarters · filed 2020-03-25 | -$315.00K derived: sum of 4 quarters · filed 2020-03-25 | ||||
| 2017-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $140.00K derived: sum of 2 quarters · filed 2020-03-25 | -$141.00K derived: sum of 3 quarters · filed 2020-03-25 | -$97.00K 10-K · filed 2020-03-25 | ||||
| 2017-09-30 | $35.00K 10-Q · filed 2018-11-07 | -$246.00K derived: sum of 2 quarters · filed 2018-11-07 | -$202.00K 10-Q · filed 2018-11-07 | -$621.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$281.00K 10-Q · filed 2018-08-06 | -$237.00K 10-Q · filed 2018-08-06 | -$656.00K derived: sum of 3 quarters · filed 2019-03-13 | -$945.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | $44.00K 10-Q · filed 2018-05-07 | -$375.00K derived: sum of 2 quarters · filed 2019-03-13 | -$664.00K derived: sum of 3 quarters · filed 2019-03-13 | -$558.00K derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$708.00K derived: sum of 2 quarters · filed 2019-03-13 | -$602.00K derived: sum of 3 quarters · filed 2019-03-13 | -$92.00K 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | -$289.00K 10-Q · filed 2017-11-07 | -$183.00K derived: sum of 2 quarters · filed 2017-11-07 | $327.00K 10-Q · filed 2017-11-07 | $135.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $106.00K 10-Q · filed 2017-08-07 | $616.00K 10-Q · filed 2017-08-07 | $424.00K derived: sum of 3 quarters · filed 2018-03-12 | $424.00K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $510.00K 10-Q · filed 2017-05-08 | $318.00K derived: sum of 2 quarters · filed 2018-03-12 | $318.00K derived: sum of 3 quarters · filed 2018-03-12 | |||||
| 2015-12-31 | -$192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$192.00K derived: sum of 2 quarters · filed 2018-03-12 | -$192.00K 10-K · filed 2018-03-12 | |||||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | -$50.00K 10-Q · filed 2015-11-12 | $0.00 10-Q · filed 2016-11-10 | -$50.00K 10-Q · filed 2015-11-12 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |